Spine (Thoracic and Vertebra) Department, the Second Affiliated Hospital of Inner Mongolia University, #1 Yingfang Road, Hohhot, 010050, Inner Mongolia, China.
Inner Mongolia People's Hospital, Hohhot, Inner Mongolia, China.
J Orthop Surg Res. 2019 Jul 30;14(1):243. doi: 10.1186/s13018-019-1254-2.
Lumbar disc herniation, a type of chronic low back pain syndrome, is caused by the lumbar intervertebral disk degeneration. Genetic variation in the CHRNA5/CHRNA3 has shown strong associations with smoking-related diseases. This study's aim is to test whether single-nucleotide polymorphisms in the CHRNA5/CHRNA3 gene are associated with lumbar disc herniation risk.
The genotype frequency distributions of the polymorphisms were detected by polymerase chain reaction-restriction fragment length polymorphism in 380 lumbar disc herniation patients (case group) and 400 healthy individuals (control group). Allelic, genotypic, and haplotype analyses were performed.
We found that the individuals with rs8040868 CT genotype had a 0.46-fold higher risk of lumbar disc herniation than those with rs8040868 TT genotype, in men group (OR = 0.46, 95% CI 0.25-0.84, p = 0.012). Also among women, rs8040868 CT + CC genotype still reduced the risk of lumbar disc herniation under the dominant model (OR = 0.50, 95% CI 0.28-0.89, p = 0.019). Haplotype analysis showed that compared with the CHRNA5 "TACAACCG" wild-type, the "TACACCCG" haplotype was found to be associated with a decreased risk of lumbar disc herniation (LDH) (OR = 0.79, 95% CI 0.63-1.00, p = 0.047), while, in the less than 50-year-old group, CHRNA5 "TACACCCG" increased the risk of LDH (OR = 1.46, 95% CI 1.01-2.13, p = 0.047).
Our data suggest that gene variance in the CHRNA5/CHRNA3 is associated with risk of lumbar disc herniation in the case-control study.
腰椎间盘突出症是一种慢性下腰痛综合征,由腰椎间盘退行性变引起。CHRNA5/CHRNA3 中的遗传变异与吸烟相关疾病有很强的关联。本研究旨在检验 CHRNA5/CHRNA3 基因中的单核苷酸多态性是否与腰椎间盘突出症的风险相关。
采用聚合酶链反应-限制性片段长度多态性检测 380 例腰椎间盘突出症患者(病例组)和 400 例健康个体(对照组)中多态性的基因型频率分布。进行等位基因、基因型和单倍型分析。
我们发现,男性组中 rs8040868 CT 基因型个体患腰椎间盘突出症的风险比 rs8040868 TT 基因型个体高 46%(OR=0.46,95%CI 0.25-0.84,p=0.012)。在女性中,rs8040868 CT+CC 基因型在显性模型下仍降低腰椎间盘突出症的风险(OR=0.50,95%CI 0.28-0.89,p=0.019)。单倍型分析显示,与 CHRNA5“TACAACCG”野生型相比,“TACACCCG”单倍型与腰椎间盘突出症(LDH)的风险降低相关(OR=0.79,95%CI 0.63-1.00,p=0.047),而在年龄小于 50 岁的人群中,CHRNA5“TACACCCG”增加了 LDH 的风险(OR=1.46,95%CI 1.01-2.13,p=0.047)。
我们的数据表明,CHRNA5/CHRNA3 中的基因变异与病例对照研究中的腰椎间盘突出症风险相关。